The venture was found in Asia in Japan. The leading representative office of defined Corporate Investor is situated in the Tokyo.
The overall number of key employees were 1.
Opposing the other organizations, this SBI Group works on 24 percentage points less the average amount of lead investments. Speaking about the real fund results, this Corporate Investor is 37 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2018. When the investment is from SBI Group the average startup value is more than 1 billion dollars. Deals in the range of 50 - 100 millions dollars are the general things for fund. The fund is constantly included in 7-12 deals per year. The higher amount of exits for fund were in 2019.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the SBI Group, startups are often financed by SBI Ven Capital, East Ventures, Route 66 Ventures. The meaningful sponsors for the fund in investment in the same round are Magma Venture Partners, Vertex Ventures Israel, Vertex Ventures. In the next rounds fund is usually obtained by AddVentures by SCG, Vertex Ventures Israel, Vertex Ventures.
Among the various public portfolio startups of the fund, we may underline Lu.com, Ping An Healthcare Management, Rakuten Medical Among the most popular fund investment industries, there are Bitcoin, Financial Services. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. For fund there is no match between the location of its establishment and the land of its numerous investments - United States.
Related Funds
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
HarvestX | $3M | 20 Mar 2024 | Bunkyo, Japan | ||
Bluwhale | $7M | 11 Mar 2024 | Santa Clara, California, United States | ||
BLOCKSMITH&Co | 15 Nov 2023 | Tokyo, Kantō, Japan | |||
Etaily | $17M | 14 Nov 2023 | Singapore, Central Region, Singapore | ||
Zodia Custody | $39M | 27 Apr 2023 | London, England, United Kingdom | ||
BANCO | $6M | 30 Aug 2022 | Singapore, Central Region, Singapore | ||
SolanaFM | $4M | 26 Aug 2022 | Singapore, Central Region, Singapore | ||
RootAnt | $4M | 16 Aug 2022 | Singapore, Central, Singapore | ||
SOLV | $40M | 27 Jun 2022 | Bengaluru, Karnataka, India |
– Rakuten Medical from San Mateo is developing and commercializing innovative oncology products for multiple indications.
– The company raised $166m in Series D funding.
– The round was led by General Catalyst with additional participation from existing investors, including Rakuten Group and SBI Group.
– The new investment will be used to advance ongoing trials of ASP-1929 in several oncologic indications and research and development of additional pipeline therapies being developed using the Illuminox™ platform.
– Heartseed, a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure (HF), announced it has raised 4 Billion-yen (approx. $37 Million) at Series C round, bringing its total financial backing to 8.2 Billion yen (approx. $75 Million) since its foundation in 2015.
– New investors are UTokyo Innovation Platform Co. (UTokyo IPC), Medical Incubator Japan, Keio Innovation Initiative (KII), and Sumitomo Mitsui Trust Investment. Among the existing investors, SBI Group, Nissay Capital, SMBC Capital, Medipal Holdings, and Itochu Chemical Frontier participated in this round.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
HarvestX | $3M | 20 Mar 2024 | Bunkyo, Japan | ||
Bluwhale | $7M | 11 Mar 2024 | Santa Clara, California, United States | ||
BLOCKSMITH&Co | 15 Nov 2023 | Tokyo, Kantō, Japan | |||
Etaily | $17M | 14 Nov 2023 | Singapore, Central Region, Singapore | ||
Zodia Custody | $39M | 27 Apr 2023 | London, England, United Kingdom | ||
BANCO | $6M | 30 Aug 2022 | Singapore, Central Region, Singapore | ||
SolanaFM | $4M | 26 Aug 2022 | Singapore, Central Region, Singapore | ||
RootAnt | $4M | 16 Aug 2022 | Singapore, Central, Singapore | ||
SOLV | $40M | 27 Jun 2022 | Bengaluru, Karnataka, India |
